Skip to main content
DBD
NYSE Technology

10% Owner Files Intent to Sell $35M in Shares Near 52-Week Highs

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$69.91
Mkt Cap
$2.507B
52W Low
$34.875
52W High
$72.295
Market data snapshot near publication time

summarizeSummary

A 10% owner, Millstreet Capital Management LLC, has filed to sell $35.1 million worth of Diebold Nixdorf shares, representing a significant portion of their holdings, as the stock trades near its 52-week high.


check_boxKey Events

  • Proposed Share Sale

    Millstreet Capital Management LLC, a 10% stockholder, intends to sell 500,000 common shares of Diebold Nixdorf, with an approximate market value of $35.1 million.

  • Significant Stake Reduction

    The proposed sale represents a significant portion of Millstreet Capital Management's total holdings in the company.

  • Trading Near 52-Week High

    The filing occurs while Diebold Nixdorf's stock is trading near its 52-week high, potentially indicating the investor is realizing gains.

  • Prior Sales Activity

    This intent to sell follows previous sales by Millstreet Capital Management LLC of 251,726 shares, generating $15.9 million in gross proceeds, over the past three months.


auto_awesomeAnalysis

Millstreet Capital Management LLC, a 10% stockholder, has filed a Form 144 indicating its intent to sell 500,000 common shares of Diebold Nixdorf, valued at approximately $35.1 million. This proposed sale represents a notable reduction in their stake, following previous sales in the last three months. The timing, with the stock trading near its 52-week high, suggests the investor may be locking in gains. While 10% owners often sell for portfolio rebalancing, a transaction of this size could create selling pressure.

At the time of this filing, DBD was trading at $69.91 on NYSE in the Technology sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $34.88 to $72.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DBD - Latest Insights

DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Apr 10, 2026, 4:04 PM EDT
Filing Type: 4
Importance Score:
7
DBD
Feb 12, 2026, 4:38 PM EST
Filing Type: 10-K
Importance Score:
9
DBD
Feb 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
DBD
Jan 20, 2026, 4:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Jan 20, 2026, 4:10 PM EST
Filing Type: 4
Importance Score:
7
DBD
Jan 15, 2026, 4:40 PM EST
Filing Type: 144
Importance Score:
7